These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials. Moss AJ Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293 [No Abstract] [Full Text] [Related]
10. Central Venous Stenosis after Hemodialysis: Case Reports and Relationships to Catheters and Cardiac Implantable Devices. Pacilio M; Borrelli S; Conte G; Minutolo R; Musumeci A; Brunori G; Veniero P; De Falco V; Provenzano M; De Nicola L; Garofalo C Cardiorenal Med; 2019; 9(3):135-144. PubMed ID: 30814478 [TBL] [Abstract][Full Text] [Related]
12. Implantable cardiac electronic device therapy for patients with a systemic right ventricle. Barracano R; Brida M; Guarguagli S; Palmieri R; Diller GP; Gatzoulis MA; Wong T Heart; 2020 Jul; 106(14):1052-1058. PubMed ID: 32269130 [TBL] [Abstract][Full Text] [Related]
13. Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study. Özcan C; Raunsø J; Lamberts M; Køber L; Lindhardt TB; Bruun NE; Laursen ML; Torp-Pedersen C; Gislason GH; Hansen ML Europace; 2017 Jun; 19(6):1007-1014. PubMed ID: 28073883 [TBL] [Abstract][Full Text] [Related]
14. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon. Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous placement of leadless pacemaker and dialysis catheter in patient with exhausted vasculature. Bednarczyk D; Kuliczkowski W; Letachowicz K; Dzidowski M; Witkowski T; Krajewska M; Kusztal M; Mysiak A; Ściborski K; Mitkowski P J Vasc Access; 2021 Jan; 22(1):147-150. PubMed ID: 31868084 [TBL] [Abstract][Full Text] [Related]
16. Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infections. Dhamija RK; Tan H; Philbin E; Mathew RO; Sidhu MS; Wang J; Saour B; Haqqie SS; Beathard G; Yevzlin AS; Salman L; Boden WE; Siskin G; Asif A Am J Kidney Dis; 2015 Jul; 66(1):154-8. PubMed ID: 25911316 [TBL] [Abstract][Full Text] [Related]
17. Placement issues of hemodialysis catheters with pre-existing central lines and catheters. Aurshina A; Hingorani A; Alsheekh A; Kibrik P; Marks N; Ascher E J Vasc Access; 2018 Jul; 19(4):366-369. PubMed ID: 29542366 [TBL] [Abstract][Full Text] [Related]
18. Predictors for early mortality and arrhythmic events in patients with cardiac resynchronization therapy with defibrillator: A two center cohort study. Gunten SV; Theuns DA; Kühne M; Reichlin T; Sticherling C; Schaer B Cardiol J; 2019; 26(6):711-716. PubMed ID: 30484267 [TBL] [Abstract][Full Text] [Related]
20. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort. Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]